loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find Poly DL Lactide, Poly DL Lactide co Glycolide , Poly L Lactide, Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient offered by Nomisma Healthcare for stability, solubility & bioavailability enhancement on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Injectable / Parenteral

02 5Tablet

filter clear-filterReset all filters

PharmaCompass

01

arrow
FNCE 2024
Not Confirmed

02

arrow
FNCE 2024
Not Confirmed

03

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Nomisma Healthcare

Excipient Details : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow

Brand : PLLA

Applications : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow
blank

04

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Nomisma Healthcare

Excipient Details : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow

Brand : PDLLA

Applications : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

Grade : Oral, Parenteral

arrow
blank

05

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Nomisma Healthcare

Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

arrow

Brand : PLGA

Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

arrow
blank